Full Text
Análisis De Costo-Efectividad De Bevacizumab Para El Tratamiento De Primera Línea En Pacientes Con Cáncer Colorrectal Metastásico, Ccrm En Colombia

Abstract

Authors

L.A. parada Vargas D.A. Barbosa

Back to Volume 16, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×